Roger Gilabert-Oriol

3PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 19, 2019
Liposomal OTS964, a TOPK inhibitor: a simple method to estimate OTS964 association with liposomes that relies on enhanced OTS964 fluorescence when bound to albumin.

Roger Gilabert-Oriol, Brent W Sutherland, Malathi Anantha

|May 26, 2017
Optimization of liposomal topotecan for use in treating neuroblastoma.

Lina Chernov, Rebecca J Deyell, Malathi Anantha

|Apr 23, 2017
In vitro assay for measuring real time topotecan release from liposomes: release kinetics and cellular internalization.

Roger Gilabert-Oriol, Lina Chernov, Malathi Anantha

Pageof 1

Frequent Collaborators